|
Aug 10
|
ABVC BioPharma Regains Compliance With Nasdaq's Minimum Bid Price Requirement
|
|
Aug 7
|
ABVC Corporate Update and CEO's Letter to Shareholders
|
|
Jun 26
|
ABVC BioPharma, Inc. Announces New CEO as It Targets Further Growth
|
|
Jun 20
|
ABVC BioPharma Subsidiary BioKey Projects $1.0 Million Proceeds From Dietary Supplement Production
|